These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 24708472)

  • 21. Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory distress syndrome and pulmonary fibrosis.
    Gazzaniga G; Voltini M; Carletti A; Lenta E; Meloni F; Briganti DF; Avanzini MA; Comoli P; Belliato M
    Respir Res; 2024 Apr; 25(1):170. PubMed ID: 38637860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS.
    Wick KD; Leligdowicz A; Zhuo H; Ware LB; Matthay MA
    JCI Insight; 2021 Jun; 6(12):. PubMed ID: 33974564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19: A Randomized, Placebo-Controlled Dosing Clinical Trial.
    Lightner AL; Sengupta V; Qian S; Ransom JT; Suzuki S; Park DJ; Melson TI; Williams BP; Walsh JJ; Awili M
    Chest; 2023 Dec; 164(6):1444-1453. PubMed ID: 37356708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YAP-regulated type II alveolar epithelial cell differentiation mediated by human umbilical cord-derived mesenchymal stem cells in acute respiratory distress syndrome.
    Chen XY; Chen KY; Feng PH; Lee KY; Fang YT; Chen YY; Lo YC; Bhavsar PK; Chung KF; Chuang HC
    Biomed Pharmacother; 2023 Mar; 159():114302. PubMed ID: 36701989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; McAuley DF; O'Kane C
    Trials; 2022 May; 23(1):401. PubMed ID: 35562778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Spinocerebellar Ataxia With Mesenchymal Stem Cells: A Phase I/IIa Clinical Study.
    Tsai YA; Liu RS; Lirng JF; Yang BH; Chang CH; Wang YC; Wu YS; Ho JH; Lee OK; Soong BW
    Cell Transplant; 2017 Mar; 26(3):503-512. PubMed ID: 28195034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: a randomized, placebo-controlled clinical trial in eight cats.
    Quimby JM; Webb TL; Randall E; Marolf A; Valdes-Martinez A; Dow SW
    J Feline Med Surg; 2016 Feb; 18(2):165-71. PubMed ID: 25784460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial.
    Sun Q; Huang Z; Han F; Zhao M; Cao R; Zhao D; Hong L; Na N; Li H; Miao B; Hu J; Meng F; Peng Y; Sun Q
    J Transl Med; 2018 Mar; 16(1):52. PubMed ID: 29514693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
    Ranieri VM; Pettilä V; Karvonen MK; Jalkanen J; Nightingale P; Brealey D; Mancebo J; Ferrer R; Mercat A; Patroniti N; Quintel M; Vincent JL; Okkonen M; Meziani F; Bellani G; MacCallum N; Creteur J; Kluge S; Artigas-Raventos A; Maksimow M; Piippo I; Elima K; Jalkanen S; Jalkanen M; Bellingan G;
    JAMA; 2020 Feb; 323(8):725-733. PubMed ID: 32065831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial.
    Gorman EA; Rynne J; Gardiner HJ; Rostron AJ; Bannard-Smith J; Bentley AM; Brealey D; Campbell C; Curley G; Clarke M; Dushianthan A; Hopkins P; Jackson C; Kefela K; Krasnodembskaya A; Laffey JG; McDowell C; McFarland M; McFerran J; McGuigan P; Perkins GD; Silversides J; Smythe J; Thompson J; Tunnicliffe WS; Welters IDM; Amado-Rodríguez L; Albaiceta G; Williams B; Shankar-Hari M; McAuley DF; O'Kane CM
    Am J Respir Crit Care Med; 2023 Aug; 208(3):256-269. PubMed ID: 37154608
    [No Abstract]   [Full Text] [Related]  

  • 31. Umbilical Cord-derived Mesenchymal Stem Cells with Surfactant Protein B Alleviates Inflammatory Response in Acute Respiratory Distress Syndrome by Regulating Macrophage Polarization.
    Xu H; Nie G; Yin T; Shao C; Ding D; Zou M
    Balkan Med J; 2022 Mar; 39(1):130-139. PubMed ID: 35330560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome.
    Han J; Liu Y; Liu H; Li Y
    Stem Cell Res Ther; 2019 Dec; 10(1):386. PubMed ID: 31843004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome.
    Taher A; Lashgari M; Sedighi L; Rahimi-Bashar F; Poorolajal J; Mehrpooya M
    Pharmacol Rep; 2021 Dec; 73(6):1650-1659. PubMed ID: 34114174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: a randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome.
    Perkins GD; Gates S; Lamb SE; McCabe C; Young D; Gao F
    Trials; 2011 May; 12():113. PubMed ID: 21554679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19-Related Acute Respiratory Distress Syndrome.
    Shaz BH; Kraft BD; Troy JD; Poehlein E; Chen L; Cheatham L; Manyara R; Hanafy K; Brown L; Scott M; Palumbo R; Vrionis F; Kurtzberg J
    Stem Cells Transl Med; 2023 Apr; 12(4):185-193. PubMed ID: 36929827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of human mesenchymal stem cells impacts their therapeutic abilities in lung injury by increasing interleukin (IL)-10 and IL-1RN levels.
    Bustos ML; Huleihel L; Meyer EM; Donnenberg AD; Donnenberg VS; Sciurba JD; Mroz L; McVerry BJ; Ellis BM; Kaminski N; Rojas M
    Stem Cells Transl Med; 2013 Nov; 2(11):884-95. PubMed ID: 24089414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eicosapentaenoic acid potentiates the therapeutic effects of adipose tissue-derived mesenchymal stromal cells on lung and distal organ injury in experimental sepsis.
    Silva JD; Lopes-Pacheco M; de Castro LL; Kitoko JZ; Trivelin SA; Amorim NR; Capelozzi VL; Morales MM; Gutfilen B; de Souza SAL; Weiss DJ; Diaz BL; Rocco PRM
    Stem Cell Res Ther; 2019 Aug; 10(1):264. PubMed ID: 31443678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for in-hospital mortality in recipients of allogeneic hematopoietic stem cell transplantation with acute respiratory distress syndrome: a retrospective study based on the 2023 new definition of acute respiratory distress syndrome.
    Guo S; Xie D; Gao Y; Yang L; Chen J; He Y; Sun Y; He S; Chen F; Wang Y; Guo Q
    BMC Pulm Med; 2024 Aug; 24(1):391. PubMed ID: 39138459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
    Qu W; Wang Z; Hare JM; Bu G; Mallea JM; Pascual JM; Caplan AI; Kurtzberg J; Zubair AC; Kubrova E; Engelberg-Cook E; Nayfeh T; Shah VP; Hill JC; Wolf ME; Prokop LJ; Murad MH; Sanfilippo FP
    Stem Cells Transl Med; 2020 Sep; 9(9):1007-1022. PubMed ID: 32472653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment.
    Wang W; Lei W; Jiang L; Gao S; Hu S; Zhao ZG; Niu CY; Zhao ZA
    J Transl Med; 2021 May; 19(1):198. PubMed ID: 33971907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.